XML 31 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of assumptions used in estimation of fair value of the share-based payment awards on the grant date

The fair value of the Company’s stock options granted during the three months ended March 31, 2019 and 2018 was estimated on the grant dates using the Black-Scholes valuation option-pricing model with the following assumptions:

 

     Three Months Ended
March 31,
 
     2019     2018  

Risk-free interest rate

     2.5     2.2

Volatility

     128.4     109.5

Expected life (years)

     3 - 5       4.0  

Dividend yield

     —       —  
Summary of option and RSU activity under Amended and Restated 2000 Stock Option and Equity Incentive Plan and Amended and Restated 2010 Equity Incentive Plan

A summary of option and RSU activity under the Company’s Amended and Restated 2010 Equity Incentive Plan (the Plan) is presented below (in thousands, except exercise price):

 

            Options outstanding  
     Shares
Available
for Grant
     Number of
Shares
     Weighted
Average
Exercise
Prices
 

Balance at January 1, 2019

     4,007        337      $ 4.19  

Additional shares authorized under the Plan

     50        —          —    

RSUs granted

     (2,028      —          —    

RSUs cancelled and returned to the Plan

     11        —          —    

Options granted

     (1,297      1,297      $ 0.20  

Options cancelled and returned to the Plan

     1        (1    $ 7.20  
  

 

 

    

 

 

    

Balance at March 31, 2019

     744        1,633      $ 1.02  
  

 

 

    

 

 

    
Summary of RSU activity under the Plan

A summary of RSU activity under the Plan is presented below (in thousands, except for fair value):

 

     Number of
Shares
     Weighted
Average
Grant-Date
Fair Value
 

Non-vested shares at December 31, 2018

     272      $ 1.23  

Granted

     2,028      $ 0.20  

Vested

     (167    $ 1.48  

Cancelled

     (11    $ 1.26  
  

 

 

    

Non-vested shares at March 31, 2019

     2,122      $ 0.23  
  

 

 

    
Summary of significant ranges of outstanding and exercisable options

The following table summarizes significant ranges of outstanding and exercisable options as of March 31, 2019 (in thousands, except contractual life and exercise price):

 

     Options Outstanding      Options Exercisable  

Range of Exercise Price

   Number
Outstanding
     Weighted
Average
Remaining
Contractual
Life

(in Years)
     Weighted
Average
Exercise
Price
     Number
Exercisable
     Weighted
Average
Exercise
Price
     Aggregate
Intrinsic
value
 

$0.18 - $0.74  

     1,297        2.80      $ 0.20        30      $ 0.20      $ —    

$0.75 - $1.27  

     160        4.55      $ 0.75        53      $ 0.75      $ —    

$1.28 - $7.19  

     51        5.15      $ 2.09        23      $ 2.93      $ —    

$7.20 - $20.49  

     106        7.04      $ 7.20        92      $ 7.20      $ —    

$20.50 - $46.20  

     19        5.94      $ 21.53        19      $ 21.53      $ —    
  

 

 

          

 

 

       

 

 

 

$0.18 - $46.20  

     1,633        5.52      $ 1.02        217      $ 5.46      $ —